Ultrasound-mediated gene delivery of factor VIII plasmids for hemophilia A gene therapy in mice
Gene therapy offers great promises for a cure of hemophilia A resulting from factor VIII (FVIII) gene deficiency. We have developed and optimized a non-viral ultrasound-mediated gene delivery (UMGD) strategy. UMGD of reporter plasmids targeting mice livers achieved high levels of transgene expressio...
Saved in:
Main Authors: | Shuxian Song (Author), Meghan J. Lyle (Author), Misty L. Noble-Vranish (Author), Dominic M. Min-Tran (Author), James Harrang (Author), Weidong Xiao (Author), Evan C. Unger (Author), Carol H. Miao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles
by: Chun-Yu Chen, et al.
Published: (2020) -
Influence of Nanobubble Size Distribution on Ultrasound-Mediated Plasmid DNA and Messenger RNA Gene Delivery
by: Hiroshi Kida, et al.
Published: (2022) -
Plasmid-Mediated Transfer of Antibiotic Resistance Genes in Soil
by: Miaoling Meng, et al.
Published: (2022) -
Exosomes as an Emerging Plasmid Delivery Vehicle for Gene Therapy
by: Margaret Wallen, et al.
Published: (2023) -
Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A
by: Jie Gong, et al.
Published: (2023)